Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Murli Krishna Pharma Pvt. Ltd.

6,244 views

Published on

Murli Krishna Pharma Private Ltd is a young and dynamic drug delivery systems (DDS) company in India that provides a range of effective solutions to optimize the delivery of pharmaceutical products.

Murli Krishna Pharma is an R&D-driven organization that offers a complete range of oral delivery technologies including :
Controlled and Delayed Release Matrix
Multiparticulate Deliveries
Extended Release Technologies

Published in: Health & Medicine, Business
  • Be the first to comment

  • Be the first to like this

Murli Krishna Pharma Pvt. Ltd.

  1. 1. Murli Krishna Pharma Pvt. Ltd. Innovative Solutions for Oral Dosage Forms….. Factory : D-98, Ranjangaon, M.I.D.C., Ranjangaon, Taluka-Shirur, District – Pune, 412209 – Maharashtra. TEL.:00-91-2138 660771,660772. Fax: 00-91-2138232530. Cop. Office: No. 8, Pearl Bldg., Powai Vihar Complex, A.S.Marg, Powai, Mumbai – 400 076. India. Tel. : 00-91-22-25708138/3598/Fax : 00-91-22-25702054. Email: mkepl@vsnl.com Web Site: www.mkppl.com ……… .we turn ideas into technology
  2. 2. Company Profile <ul><li>MKPPL is a Research based company manufacturing high value drug products in the form of Enteric Coated Pellets. </li></ul><ul><li>European GMP certified plant for Omeprazole pellets </li></ul><ul><li>100% Export Oriented Unit (EOU) </li></ul><ul><li>Single stop for Coating Solutions </li></ul><ul><li>Commercial Production started in October 2005 </li></ul><ul><li>Compliance with regulatory standards – Both Indian and International </li></ul>
  3. 3. Vision <ul><li>Turning Technology dreams into reality. </li></ul><ul><li>Mission </li></ul><ul><li>Become a Global Pharmaceutical export company </li></ul><ul><li>Continuing the development of Aqueous based Coating Techniques . </li></ul><ul><li>Extending our expertise in designing Solid Dosage forms for Stents moving from the current Micro Encapsulation to Nano Encapsulation Using Aqueous Dispersion Techniques. </li></ul><ul><li>Focusing on N ew and Novel Drug Deliveries with an eye on Patents </li></ul>
  4. 4. Our Strengths <ul><li>Right products </li></ul><ul><li>Right people </li></ul><ul><li>Right infrastructure </li></ul><ul><li>Right environment </li></ul><ul><li>Deliver quality product on time at competitive price </li></ul><ul><li>Right quality procedures in practice </li></ul>
  5. 5. Right Products <ul><li>*Patent non infringing </li></ul>Product Strength Pellet Size Category Omeprazole Pellets 8.5%,10 % 14#18 16#20 Anti-ulcerant Lansoprazole Pellets 8.5% 14#18 24#30 Anti-ulcerant Itraconazole Pellets 22% 14#18 Anti-ulcerant Esomeprazole Pellets 8.5% & 22.5%,22% 14#18 16#20 Anti-ulcerant Pantoprazole Pellets 15% ,22% 14#18 Anti-ulcerant Tacrolimus Pellets 0.5%, 1% & 5% --- Immune-Suppressant Clarithromycin Pellets 40% 20#30 Macrolide Orlistat Pellets 50% -- Anti-obesity Mesalazine Pellets 70% ---- Anti-ulcerant
  6. 6. Right Products <ul><li>New Molecules in pipeline </li></ul><ul><li>Rapamycin (Sirolimus) Pellets 0.5%, 1%, 5% </li></ul><ul><li>Mycophenolate Mofitil Pellets 50% </li></ul><ul><li>Paclitaxel Pellets 25%, 50% </li></ul><ul><li>Azithromycin Pellets 40% </li></ul><ul><li>We have a dedicated manufacturing facility for Immune-Suppressant Pellets </li></ul><ul><li>Total Plant Capacity at present : 12 MT Per Month </li></ul>
  7. 7. Advantage in using Enteric coated pellets Manufactured by MKPPL <ul><li>Ready to fill any size of capsules. </li></ul><ul><li>No processing prior to capsule and dry syrup filling resulting. in substantial cost and time saving. </li></ul><ul><li>Easy to make dry syrup for children . </li></ul><ul><li>No organic solvents used during coating or at any other stage of manufacturing. </li></ul><ul><li>Better in-vitro and in-vivo absorption profile (matching with innovators profile) for long term Pharmacological action </li></ul>
  8. 8. Right people <ul><li>Experienced work force and management team </li></ul>Department M.Pharm B.Pharm M.Sc B.Sc/B.E B.Com M.Com/M.A D.Pharm/D.E Other Total Production 0 3 1 3 0 0 2 6 15 Quality Assurance 3 5 1 2 0 0 0 0 11 Quality Control 0 3 6 1 0 0 2 0 12 Warehouse 0 0 0 1 1 0 0 3 5 Engineering 0 0 0 0 0 0 1 7 8 Human Resources 0 0 0 0 0 2 0 0 2 Administration 0 0 0 0 0 1 1 2 5 Product Development Lab. 4 1 1 0 0 0 0 1 7 I.T. 0 0 0 1 0 0 0 0 1 Total 66
  9. 9. ORGANOGRAM Director Administration Mrs. Sitamahalakshmi Challa Technical Director Dr. Vijay K. Shastri GM Manufacturing Operations Mr. A. V. Kulkarni Logistics CMD Mrs. Satya R. Vadlamani Purchase FDA Liaison Mr. K. V. Narale Chief Finance Officer Mr. R. V. Ranjan Director Business Development & Technical Services Dr. Pramod P. Karkhanis Material Management & Procurement Material Inventory Control & Product Inventory Control DGM QC Ms. Sushila Kumari Human Resources Global Business Development, Global Regulatory Compliance Ms.Tahera Dashti Head Process Development Laboratory Mr. T. Phanikumar Research & Development Head Accounts Department Ms. S. S. More GM Quality Assurance & Regulatory Affairs Mr. R. B. Patil DGM Quality Assurance & Regulatory compliance Mr.S.B.Bhalekar Mr. S. B. Bhalekar Manager Engineering & Maintenance Mr. D. M. Deshmukh Senior DGM Production Material Handling, Store , Dispatch, Distribution. Mr. T.K.Halande Asst.Mgr. QA&RA Ms.Kavita Godase
  10. 10. Management Team <ul><li>Mrs. Satya Vadlamani </li></ul><ul><li>Chairperson and Managing Director </li></ul><ul><li>Dr. Vijay K Shastri </li></ul><ul><li>Director-Technical </li></ul><ul><li>Dr.Pramod P. Karkhanis </li></ul><ul><li>Director-Business Development and Technical Services. </li></ul><ul><li>Mrs. C. Sitamahalaxmi </li></ul><ul><li>Director – Administration </li></ul><ul><li>Mr. Ranjan </li></ul><ul><li>CFO- Finance </li></ul>
  11. 11. Our Partners in Venture <ul><li>Rhenochem AG- Switzerland </li></ul><ul><li>Equity holders as well as marketing partners in Europe and </li></ul><ul><li>South America </li></ul><ul><li>Elcon Hongkong Ltd.---Hongkong </li></ul><ul><li>Equity holders as well as marketing represntatives in China </li></ul>
  12. 12. Our clientele European USA <ul><li>Medichrom — Greece </li></ul><ul><li>Farmoz — Portugal </li></ul><ul><li>Slavia Pharm — Romania </li></ul><ul><li>Welding Gmbh — Germany </li></ul><ul><li>Rhenochem AG – Switzerland </li></ul><ul><li>Karieb Kemi – UK </li></ul><ul><li>Mylan Inc. </li></ul><ul><li>Cutis Pharma Inc. </li></ul><ul><li>Cogentus </li></ul><ul><li>Pharmaceuticals Inc. </li></ul><ul><li>Geo Pharma Inc. </li></ul><ul><li>Neuromoleculuar </li></ul><ul><li>Synthesis </li></ul>
  13. 13. Thank You!

×